Back to search

Japan· JP-2391404A1038

パロノセトロン塩酸塩

A palonosetron product containing パロノセトロン塩酸塩, registered in Japan by 岡山大鵬薬品, on the national reimbursement list. The same ATC class is registered in 18 of our 19 countries.

On Japan’s NHI price listATC A04AA05

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedパロノセトロン塩酸塩ATCA04AA05REGISTER NO.JP-2391404A1038PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Palonosetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 10 of them publish a price we can compare per daily dose

Palonosetron · ATC A04AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Palonosetron · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$124.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
パロノセトロン塩酸塩
Manufacturer
岡山大鵬薬品
Country
Japan (JP)
ATC code
A04AA05
ATC class
Palonosetron
Defined daily dose
0.5 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for palonosetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Palonosetron · interactions on record

490 records

  • 139 severe
  • 195 moderate
  • 3 minor
  • 153 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e221f662-bf6b-4b6e-8f78-bcc061013e38
GET /v1/drugs/e221f662-bf6b-4b6e-8f78-bcc061013e38?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "0.75mg5mL1瓶",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2391404A1038",
  "category": "注射薬",
  "price_yen": 4129,
  "generic_name": "パロノセトロン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2391",
  "transitional_expiry": null
}

See everything about palonosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.